ArticleActa pharmaceutica Sinica. B2022

Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants.

Bin Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.